33 - Improving Efficiency of Radium-223 via Pharmacological Blockade of Gastrointestinal Uptake and Increase Bone targeting (ID 12) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

33 - Improving Efficiency of Radium-223 via Pharmacological Blockade of Gastrointestinal Uptake and Increase Bone targeting (ID 12)

Oncology: Basic & Translational -> Basic Science (O) 33

33 - Improving Efficiency of Radium-223 via Pharmacological Blockade of Gastrointestinal Uptake and Increase Bone targeting (ID 12)

Session Name

Center for Therapy Excellence YIA Symposium

Speakers

D. Abou

Authors

Presentation Topic

Oncology: Basic & Translational -> Basic Science (O)

Presentation Number

33

Poster Award Finalist

3rd Place

Previous Eposter

31 - The combination of ¹⁸F-FDG and ¹⁸F-NaF uptake predict the development of abdominal aortic aneurysm in rat model. (ID 698)

Next Eposters

34 - Self-Assembling and DisAssembling Bispecific Antibodies for Curative 2-step Pretargeted Radioimmunotherapy (ID 13)

35 - FLT-PET to evaluate sequencing of chemotherapies to enhance efficacy of treatment in triple negative breast cancers (ID 15)

36 - Low-dose TRT reshapes the microenvironment of prostate tumors to potentiate response to immunotherapy (ID 14)

37 - Factors predicting metastatic disease in 68Ga-PSMA-11 PET positive osseous lesions in prostate cancer (ID 1231)

38 - Diagnostic Performance of PSMA-Targeted ¹⁸F-DCFPyL PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the Phase 3, Multicenter CONDOR Study (ID 1227)

39 - Survey by the French Medicine Agency (ANSM) of the practice, result and impact of ⁶⁸Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer with non-contributive ¹⁸F-fluorocholine PET/CT: 1177 examinations (ID 1234)

40 - Preliminary results of a prospective, multicenter trial assessing the impact of ¹⁸F-DCFPyL-PET/CT on the management of patients with recurrent prostate cancer. (ID 1228)

41 - Incidence of local prostate cancer recurrence by 68Ga-PSMA-11 PET/CT is higher after definitive Radiation Therapy than after Radical Prostatectomy: a single center post-hoc retrospective analysis of recurrence patterns of 787 patients. (ID 1233)

42 - Matched-pair comparison of ⁶⁸Ga-PSMA-11 and ¹⁸F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrent prostate cancer (ID 1229)

43 - Impact of⁶⁸Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial (ID 1232)